Videos
The 5-laser BD FACSymphony™ S6 Cell Sorter is our updated cell sorter that can simultaneously identify up to 30 different cellular markers and use this information to do up to 6 way bulk sorting or single cell plating, perfect for complicated CAR-x or other rare cell isolation prior to…
Videos
This ELISpot reader is a top-tier model that enables advanced 12-color fluorescent and bright field studies. Featuring a potent zoom lens for precise resolution in single-cell and high-resolution work across well formats, its modular design allows customization for diverse imaging applications. Featuring: Shalini Gautam, Ph.D.
Videos
ARGO™ HT System using the NULISA™ technology from Alamar Biosciences uses a sequential immunocomplex capture and release mechanism combined with cutting-edge Next-Generation Sequencing to deliver attomolar sensitivity and multiplexing for the quantitation of previously hard-to-measure biomarkers. Featuring Fabien Lavocat
Videos
The 5-laser Cytek Aurora is our newest top of the line spectral flow cytometer that can identify up to 40 different cellular markers in a single experiment for expansive immunophenotyping panels or remove cellular autofluorescence for a more quantitative analysis of single markers for RO and phosphoflow assays. Featuring:…
Videos
The QX200 AutoDG Droplet Digital PCR (ddPCR) system is an advanced technology used for nucleic acid quantification with extremely high precision and sensitivity. This system operates on the principles of partitioning the DNA or RNA sample into thousands of nanoliter-sized droplets, allowing for the amplification and quantification of nucleic…
Blogs
What are functional assays? Understanding the interactions between drugs and biological systems is critical for the success of a new drug. One key tool in this process is functional assays. Functional assays in drug development are customized assays that evaluate the impact of drugs on the functionality of cells.
Podcasts
In this special 100th episode of The Weekly Bioanalysis, hosts John Perkins and Dominic Warrino are joined on camera by KCAS Bio CEO John Bucksath and Chief Commercial Officer Amy Mize to celebrate a major milestone. Together, they reflect on the podcast’s origins during the uncertainty of the COVID-19…
Blogs
Chimeric Antigen Receptor (CAR) therapies represent a maturing class of therapeutics with both significant clinical impact and significant analytical complexity. Unlike small molecules or traditional biologics, CAR‑T cells are living drugs with dynamic behavior that introduces a level of complexity that cannot be measured by just a single…
Podcasts
Episode 31 of The Conversational Flow Podcast dives deep into some of the most exciting developments currently shaping the future of cell therapy, flow cytometry, and AI-driven drug development. Our hosts, Brian and Adam, discuss major advances in allogeneic and in vivo CAR-T therapies, including how new manufacturing platforms…
Blogs
Accurately quantifying cisplatin in human plasma by LC-MS/MS can be challenging due to matrix effects caused by endogenous plasma components, particularly in hemolyzed samples. At WRIB 2025, scientists from KCAS Bio and Lilly presented a novel bioanalytical approach designed to…
Blogs
Oligonucleotide therapeutics continue to reshape drug development by targeting disease pathways at the genetic level. Antisense oligonucleotides (ASOs), small interfering RNAs (siRNAs), and antibody-RNA conjugates (ARCs) are expanding the range of treatable diseases, particularly for targets that were previously considered inaccessible to conventional therapeutics. As these modalities evolve,…
June 30
- July 1
KCAS Bio will be attending the 14th Antibody Industrial Symposium (AIS), taking place June 30-July 1 in Montpellier, France. As a premier event in the antibody and therapeutic development sector, AIS offers a unique platform for scientific exchange, collaboration, and innovation. Our presence at AIS underscores our commitment…